Healthcare provider profile · identity verified

Michael J Harmeling, MD

Family Practice · BOYNE CITY, MI · NPI 1194836502

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Lisinopril	Lisinopril	469	121
Atorvastatin Calcium	Atorvastatin Calcium	364	105
Omeprazole	Omeprazole	333	88
Tamsulosin Hcl	Tamsulosin Hcl	232	64
Simvastatin	Simvastatin	209	54
Levothyroxine Sodium	Levothyroxine Sodium	204	49
Losartan Potassium	Losartan Potassium	152	41
Hydrochlorothiazide	Hydrochlorothiazide	146	39
Metformin Hcl	Metformin Hcl	145	40
Metoprolol Succinate	Metoprolol Succinate	139	41
Atenolol	Atenolol	131	31
Furosemide	Furosemide	130	30
Amlodipine Besylate	Amlodipine Besylate	128	44
Sertraline Hcl	Sertraline Hcl	119	22
Rosuvastatin Calcium	Rosuvastatin Calcium	117	32
Eliquis	Apixaban	116	31
Glimepiride	Glimepiride	113	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	26
Alprazolam	Alprazolam	106	22
Gabapentin	Gabapentin	105	24
Allopurinol	Allopurinol	104	26
Fluoxetine Hcl	Fluoxetine Hcl	93	16
Venlafaxine Hcl Er	Venlafaxine Hcl	91	21
Meloxicam	Meloxicam	88	21
Escitalopram Oxalate	Escitalopram Oxalate	87	22
Metoprolol Tartrate	Metoprolol Tartrate	85	21
Tramadol Hcl	Tramadol Hcl	81	21
Pantoprazole Sodium	Pantoprazole Sodium	76	24
Citalopram Hbr	Citalopram Hydrobromide	66	13
Pioglitazone Hcl	Pioglitazone Hcl	66	18
Clonazepam	Clonazepam	65	suppressed
Clopidogrel	Clopidogrel Bisulfate	65	21
Potassium Chloride	Potassium Chloride	62	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	60	11
Carvedilol	Carvedilol	59	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	13
Prednisone	Prednisone	53	15
Lorazepam	Lorazepam	52	18
Finasteride	Finasteride	49	13
Albuterol Sulfate Hfa	Albuterol Sulfate	45	22
Bupropion Xl	Bupropion Hcl	45	11
Lovastatin	Lovastatin	45	13
Zolpidem Tartrate	Zolpidem Tartrate	44	16
Famotidine	Famotidine	41	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	22
Metformin Hcl Er	Metformin Hcl	40	11
Azithromycin	Azithromycin	39	34
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	37	11
Spironolactone	Spironolactone	37	12
Donepezil Hcl	Donepezil Hcl	35	suppressed
Celecoxib	Celecoxib	34	suppressed
Mounjaro	Tirzepatide	34	suppressed
Trazodone Hcl	Trazodone Hcl	34	12
Warfarin Sodium	Warfarin Sodium	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	30	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	30	16
Ventolin Hfa	Albuterol Sulfate	30	suppressed
Baclofen	Baclofen	29	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	29	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	29	suppressed
Montelukast Sodium	Montelukast Sodium	28	suppressed
Risperidone	Risperidone	28	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	27	suppressed
Methenamine Hippurate	Methenamine Hippurate	27	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Divalproex Sodium	Divalproex Sodium	25	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	25	suppressed
Sucralfate	Sucralfate	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Xarelto	Rivaroxaban	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Alendronate Sodium	Alendronate Sodium	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	21	18
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	20	suppressed
Temazepam	Temazepam	20	suppressed
Erythromycin	Erythromycin Base	19	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	19	suppressed
Humalog Kwikpen U-100	Insulin Lispro	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Olanzapine	Olanzapine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Gemfibrozil	Gemfibrozil	17	suppressed
Glipizide	Glipizide	17	suppressed
Oxycodone Hcl	Oxycodone Hcl	17	suppressed
Carbamazepine	Carbamazepine	16	suppressed
Jardiance	Empagliflozin	16	suppressed
Nystatin	Nystatin	16	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Methylprednisolone	Methylprednisolone	15	15
Morphine Sulfate	Morphine Sulfate	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Naproxen	Naproxen	15	suppressed
Dutasteride	Dutasteride	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Jantoven	Warfarin Sodium	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	13
Dexlansoprazole Dr	Dexlansoprazole	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Enalapril Maleate	Enalapril Maleate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Ozempic	Semaglutide	11	suppressed
Sotalol	Sotalol Hcl	11	suppressed
Synthroid	Levothyroxine Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error